Fig. 2From: ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon productionExploration of biological processes and pathways related to low ARID1A expression in EGFR-mutant lung adenocarcinoma cell lines using a multiomics method. A Evaluation of ARID1A protein expression after construction of the ARID1A knockdown cell line. B PCA based on RNA samples for RNA-seq sequencing. C Volcano plot shows differentially expressed genes revealed by RNA-seq sequencing. D Heatmap for differentially expressed genes revealed by RNA-seq sequencing; E1, E2 Enrichment analysis based on upregulated genes in ARID1A knockdown cells revealed by RNA-seq sequencing. F Enrichment analysis based on differentially expressed proteins revealed by mass spectrometry for upregulated phosphorylated proteins in ARID1A-knockdown cellsBack to article page